Clinical Trials Logo
  1. Home
  2. Pituitary Tumor
  3. NCT03719781
  4. Details
NCT03719781 Clinical Trial

Postoperative Cognitive Dysfunction in Patients Undergoing Pituitary Removal Surgery

Pituitary Tumor Clinical Trial

Official title:
Postoperative Cognitive Dysfunction in Patients Undergoing Pituitary Removal Surgery

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT03719781
Other study ID # GOKAEK 2017/153
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 2018
Est. completion date March 2019

Study information
Verified date October 2018
Source Kocaeli University
Contact Cennet Tor Kiliç
Phone +903038248
Email cennetmfk34@gmail.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

As postoperative cognitive dysfunction rates are high especially in elder patients, cognitive dysfunction is not diagnosed and treated effectively. This statement is associated with prolonged hospital stays by increasing morbidity. We wanted to see the incidency of postoperative cognitive dysfunction in patients undergoing elective pituitary tumor removal surgery.

Recruitment information / eligibility
Status Recruiting
Enrollment 90
Est. completion date March 2019
Est. primary completion date February 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- ASA I-II patients

- Undergoing elective pituitery tumor removal surgery

Exclusion Criteria:

- >II ASA scores

- Using antidepressant agents

- Patient refusal

- Mental diseases

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• standardized minimental testing
To diagnose postoperative cognitive dysfunction

Locations
Country Name City State
Turkey Kocaeli University Kocaeli

Sponsors (1)
Lead Sponsor Collaborator
Kocaeli University

Country where clinical trial is conducted

Turkey, 

Outcome
Type Measure Description Time frame Safety issue
Primary minimental test score scores between 0-30 preoperative 24th hour
Primary minimental test score scores between 0-30 postoperative 4th hour
Primary minimental test score scores between 0-30 postoperative 24th hour
Primary minimental test score scores between 0-30 one month after discharged
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04529356 - The TMS Treatment for Postoperative Headache in GH Tumor N/A
Completed NCT03363126 - Visual Outcome After Transsphenoidal Surgery for Pituitary Macroadenoma N/A
Completed NCT04212793 - Detection of PitNET Tissue During TSS Using Bevacizumab-800CW Phase 1
Recruiting NCT03309319 - A Pilot Study of Rosiglitazone in the Treatment of GH Secreting Pituitary Adenomas N/A
Terminated NCT04106531 - Validation of a Quality of Life Metric "Prolac-10"
Recruiting NCT01556230 - Prospective Study of Clinically Nonfunctioning Pituitary Adenomas
Recruiting NCT03132259 - Comparative Low and High Dose of Dexmedethomidine in Pituitary Tumor Removal by Transphenoid Approach Phase 4
Recruiting NCT01368133 - The Observational Study of Growth Hormone-secreting Pituitary Tumors N/A
Withdrawn NCT04863339 - Tranexamic Acid for Blood Loss Minimization in Endoscopic Pituitary Surgery Phase 2
Terminated NCT00646308 - Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas N/A
Recruiting NCT00852501 - Characterization of Receptors in Non-functioning Pituitary Macroadenomas Phase 4
Completed NCT03465423 - Comparison of Propofol Requirement Between Patients With Pituitary Somatotroph Tumor and With Nonfunctioning Pituitary Tumor in Transsphenoidal Pituitary Surgery Under Total Intravenous Anesthesia
Recruiting NCT03474601 - Seoul National University Pituitary Disease Cohort Study
Recruiting NCT05139277 - Evaluation of the CONVIVO System N/A
Active, not recruiting NCT03636568 - Hyponatremia Study (Delayed Hyponatremia After Pituitary Surgery) N/A
Completed NCT02813044 - Effects of Total Intravenous Anesthesia With Propofol-remifentanil Versus Inhalational Anesthesia With Sevoflurane on Quality of Recovery in Patients Undergoing Transsphenoidal Surgery for Pituitary Tumor N/A
Recruiting NCT03973450 - Epidemiology of Pituitary Tumours: Prevalence of Associated Neoplasia
Active, not recruiting NCT04042753 - Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors Phase 2
Recruiting NCT04018963 - The Impact of Endoscopic Pituitary Surgery on Nasal Function
Not yet recruiting NCT04938401 - Construction and Application of a Risk Prediction Model Forepistaxis After Pituitary Tumor Resection